58 related articles for article (PubMed ID: 24894851)
1. Fiducial markers and spacers in prostate radiotherapy: current applications.
Ng M; Brown E; Williams A; Chao M; Lawrentschuk N; Chee R
BJU Int; 2014 Mar; 113 Suppl 2():13-20. PubMed ID: 24894851
[TBL] [Abstract][Full Text] [Related]
2. Investigation of dose perturbations and the radiographic visibility of potential fiducials for proton radiation therapy of the prostate.
Huang JY; Newhauser WD; Zhu XR; Lee AK; Kudchadker RJ
Phys Med Biol; 2011 Aug; 56(16):5287-302. PubMed ID: 21799236
[TBL] [Abstract][Full Text] [Related]
3. Real-time nonstandard-shaped gold fiducial marker tracking on x-ray fluoroscopic images for prostate radiotherapy.
Sakata Y; Umene K; Asaka S; Hirai R; Ishikawa H; Mori S
Phys Med Biol; 2024 Jan; 69(2):. PubMed ID: 38091621
[No Abstract] [Full Text] [Related]
4. Perineal Abscess Following SpaceOAR Insertion.
Azhar U; Lin J; Sayed R; Masoud Z; Zamarud A; Kaler R
Cureus; 2023 Dec; 15(12):e51050. PubMed ID: 38146336
[TBL] [Abstract][Full Text] [Related]
5. Fiducial marker implantation in prostate radiation therapy: complication rates and technique.
Fawaz ZS; Yassa M; Nguyen DH; Vavassis P
Cancer Radiother; 2014 Dec; 18(8):736-9. PubMed ID: 25451675
[TBL] [Abstract][Full Text] [Related]
6. Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife® treatment for prostate cancer--a case report.
Sumila M; Mack A; Schneider U; Storelli F; Curschmann J; Gruber G
Radiat Oncol; 2014 Aug; 9():186. PubMed ID: 25142237
[TBL] [Abstract][Full Text] [Related]
7. Application of a hydrogel spacer for postoperative salvage radiotherapy of prostate cancer.
Pinkawa M; Schubert C; Escobar-Corral N; Holy R; Eble MJ
Strahlenther Onkol; 2015 Apr; 191(4):375-9. PubMed ID: 25339311
[TBL] [Abstract][Full Text] [Related]
8. Relationship between seminal vesicle displacement and distribution of hydrogel spacer within the perirectal space in prostate radiotherapy.
Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Hashine K
Mol Clin Oncol; 2023 Oct; 19(4):78. PubMed ID: 37719041
[TBL] [Abstract][Full Text] [Related]
9. The Use of Hydrogel-Based Materials for Radioprotection.
Li Y; Liu H; Ding Y; Li W; Zhang Y; Luo S; Xiang Q
Gels; 2023 Apr; 9(4):. PubMed ID: 37102914
[TBL] [Abstract][Full Text] [Related]
10. Simple method for correcting imperfectly placed fiducial markers for image-guided radiotherapy technologies of the prostate cancer.
Gawlik-Jakubczak T
Urol Ann; 2022; 14(4):395-397. PubMed ID: 36505987
[TBL] [Abstract][Full Text] [Related]
11. Long-Term In Vitro Assessment of Biodegradable Radiopaque Composites for Fiducial Marker Fabrication.
Górecka Ż; Choińska E; Heljak M; Święszkowski W
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430842
[TBL] [Abstract][Full Text] [Related]
12. The role of image-guided radiotherapy in prostate cancer: A systematic review and meta-analysis.
Wang S; Tang W; Luo H; Jin F; Wang Y
Clin Transl Radiat Oncol; 2023 Jan; 38():81-89. PubMed ID: 36407489
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal Shock Wave Enhances the Cisplatin Efficacy by Improving Tissue Infiltration and Cellular Uptake in an Upper Urinary Tract Cancer Animal and Human-Derived Organoid Model.
Luo HL; Liu HY; Chang YL; Su YL; Huang CC; Lin XJ; Chuang YC
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572785
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of the Use of Gold Anchor™ Markers in Prostate Cancer.
Lundqvist M; Levin LÅ
Cureus; 2020 Oct; 12(10):e11229. PubMed ID: 33269157
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic prostate focal reirradiation therapy for local recurrence: preliminary results of Hartmann Oncology Radiotherapy Group.
Scher N; Bauduceau O; Bollet M; Lamallem H; Charas T; Garaud P; Foster D; Fawzi M; Labidi M; Toledano A
BJR Open; 2019; 1(1):20180027. PubMed ID: 33178921
[TBL] [Abstract][Full Text] [Related]
16. Dose reduction potential of using gold fiducial markers for kilovoltage image-guided radiotherapy.
Takei Y; Monzen H; Tamura M; Doi H; Nishimura Y
J Appl Clin Med Phys; 2020 Oct; 21(10):151-157. PubMed ID: 32959957
[TBL] [Abstract][Full Text] [Related]
17. Comparison of prostate verification with implanted gold markers in tissue surrounding the prostate and pelvic bony anatomy for external beam radiation therapy following low-dose-rate brachytherapy: a prospective clinical trial.
Kaneda T; Ohashi T; Hanada T; Takenaka K; Nishimura S; Sakayori M; Sutani S; Momma T; Shigematsu N
J Radiat Res; 2020 Sep; 61(5):784-790. PubMed ID: 32808018
[TBL] [Abstract][Full Text] [Related]
18. Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications.
Boateng F; Ngwa W
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906108
[TBL] [Abstract][Full Text] [Related]
19. Potential for BioXmark liquid fiducial marker to improve identification of superficial component of canine oral tumors for computer-based radiation therapy planning.
Clerc-Renaud B; Boss MK; Griffin LR; LaRue SM; Leary D
Can Vet J; 2019 Oct; 60(10):1072-1080. PubMed ID: 31597992
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking.
Scher N; Bollet M; Bouilhol G; Tannouri R; Khemiri I; Vouillaume A; Sellami N; Von Eyben R; Vannetzel JM; Darmon I; Rotenberg L; Lamallem H; Bauduceau O; Foster D; Toledano A
Radiat Oncol; 2019 Sep; 14(1):167. PubMed ID: 31519194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
